Key Metrics 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Unimers India Ltd (524264)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524264 NSE: Chemicals | Small Cap | Unimers India Share Price
BSE Share Price
Not Listed
Not Listed
Unimers India Ltd (524264)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524264 NSE: Chemicals | Small Cap | Unimers India Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹9 Cr.
Current Price
₹0
52-Week Low / High
₹6 / 6
TTM EPS
₹-0.5
TTM Sales
₹0 Cr.
Book Value per Share
₹-51.9
P/E Ratio
0.00
Industry PE
52.9
Price to Book (P/B)
-0.11
Price to Sales (P/S)
0.00
EV/EBITDA
-32.20
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
0.00%
Return on Assets (ROA)
-7.59%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
42.33%
Pledged shares (%) of Promoter's holding (%)
52.00%
Reserves
₹-98 Cr.
Equity
₹15.9 Cr.
Face Value
₹10
All Time Low / High
₹0.25 / 28.45
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -14.9% | -20.6% | -15.8% | -15.4% | -83.2% | 0% | 0% | 0% | 0% | 0% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 42.8 | 5.2 | 3.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales YoY Gr. | - | -87.8% | -40.6% | -100% | NA | NA | NA | NA | NA | NA | - |
| Adj EPS ⓘ | -3.2 | 6.9 | -6.2 | -10.2 | -6.3 | -20.7 | -2.5 | -1.5 | -0.9 | -1 | -0.5 |
| YoY Gr. | - | NA | -190.7% | NA | NA | NA | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | -1.8 | 0.9 | -5.7 | -15.9 | -23.2 | -43.9 | -46.4 | -47.9 | -49.6 | -51.4 | -51.9 |
| Adj Net Profit ⓘ | -16.8 | 10.9 | -9.9 | -16.2 | -10 | -32.9 | -4 | -2.3 | -1.4 | -1.6 | -1 |
| Cash Flow from Ops. ⓘ | 1.9 | -2.3 | -9 | -0.9 | -0.2 | -3.9 | -1.8 | -0.2 | -0.4 | -0 | - |
| Debt/CF from Ops. ⓘ | 26.5 | -24.3 | -5.9 | -64.6 | -22 | -1.9 | -5.4 | -53.1 | -25.9 | -263.4 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -100% | NA | NA | NA | ||||
| Adj EPS ⓘ | NA | NA | NA | NA | ||||
| BVPSⓘ | NA | NA | NA | NA | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -121 | 60.6 | -78.7 | 252.4 | 49.1 | 77.2 | 6.5 | 3.6 | 2.1 | 2.3 | 1 |
| Op. Profit Mgn % ⓘ | -21.7 | -198.2 | -179.7 | -57035.2 | 0 | 0 | 0 | 0 | 0 | 0 | NAN |
| Net Profit Mgn % ⓘ | -39.2 | 209.9 | -320.9 | -346215.3 | 0 | 0 | 0 | 0 | 0 | 0 | -INF |
| Debt to Equity ⓘ | 38.2 | 4.5 | 31.5 | -4 | -0.1 | -0.1 | -0.2 | -0.2 | -0.2 | -0.1 | - |
| Working Cap Days ⓘ | 110 | 740 | 1,590 | 9,31,065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Conv. Cycle ⓘ | 9 | 302 | 395 | 2,76,191 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 42.76 | 5.20 | 3.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses ⓘ + | 52.03 | 15.51 | 8.63 | 2.67 | 1.13 | 1.67 | 1 | 2.45 | 1.37 | 1.08 |
| Operating Profit ⓘ | -9.26 | -10.31 | -5.55 | -2.67 | -1.13 | -1.67 | -1 | -2.45 | -1.37 | -1.08 |
| Operating Profit Margin (%) | -21.7% | -198.0% | -179.0% | -57,035.2% | - | - | - | - | - | - |
| Other Income ⓘ + | 4.72 | 0.73 | 1.06 | 0.01 | 0.01 | 0.36 | 0.07 | 0.23 | 0.23 | 0.17 |
| Interest ⓘ | 4.04 | 3.93 | 2.42 | 3.52 | 3.31 | 0.14 | 0.63 | 0.63 | 0.02 | 0.03 |
| Depreciation ⓘ | 4.86 | 4.86 | 4.87 | 4.85 | 4.84 | 4.83 | 2.39 | 0.45 | 0.20 | 0.20 |
| Profit Before Tax ⓘ | -13.83 | -18.37 | -12.97 | -11.03 | -11.64 | -6.29 | -3.95 | -2.30 | -1.37 | -2.76 |
| Tax ⓘ | 0.06 | -29.32 | -2.41 | 5.17 | 0 | 26.61 | 0 | 0 | 0 | 0 |
| Profit After Tax | -13.89 | 10.95 | -10.56 | -16.19 | -11.64 | -32.90 | -3.95 | -2.30 | -1.37 | -2.76 |
| PAT Margin (%) | -32.5% | 210.6% | -342.0% | -3,46,215.4% | - | - | - | - | - | - |
| Adjusted EPS (₹) | -2.6 | 6.9 | -6.6 | -10.2 | -7.3 | -20.7 | -2.5 | -1.5 | -0.9 | -1.7 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Valuation of Unimers India - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 1.29 | 12.24 | 1.68 | -14.51 | -26.15 | -59.05 | -62.99 | -65.30 | -68.13 | -70.89 | |
| Debt + | 49.30 | 55.24 | 52.96 | 57.47 | 3.20 | 7.41 | 9.76 | 10.65 | 11.02 | 9.04 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 10.97 | 9.78 | 5.68 | 5.33 | 10.05 | 9.69 | 8.23 | 7.11 | 7.13 | 8.87 | |
| Others Liabilities ⓘ | 18.54 | -1.73 | 10.16 | 11.56 | 66.75 | 85.22 | 84.31 | 85.79 | 86.46 | 89.23 | |
| Total Liabilities ⓘ | 80.10 | 75.53 | 70.47 | 59.84 | 53.85 | 43.27 | 39.30 | 38.26 | 36.48 | 36.25 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 63.90 | 59.12 | 54.26 | 49.41 | 44.57 | 39.72 | 37.33 | 36.87 | 35.21 | 35.01 | |
| CWIP ⓘ | 2.58 | 2.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Inventories | 6.41 | 6.49 | 2.43 | 1.69 | 1.03 | 0.67 | 0.50 | 0.03 | 0 | 0 | |
| Trade Receivables | 0.98 | 2.09 | 3.55 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash Equivalents | 1.77 | 0.74 | 0.51 | 0.30 | 0.08 | 0.18 | 0.10 | 0.16 | 0.08 | 0.02 | |
| Others Assets ⓘ | 4.46 | 4.16 | 9.72 | 8.44 | 8.17 | 2.70 | 1.37 | 1.20 | 1.20 | 1.22 | |
| Total Assets ⓘ | 80.10 | 75.53 | 70.47 | 59.84 | 53.85 | 43.27 | 39.30 | 38.26 | 36.48 | 36.25 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 1.86 | -2.27 | -9 | -0.89 | -0.15 | -3.94 | -1.81 | -0.20 | -0.43 | -0.03 |
| Cash Flow From Investing Activity ⓘ + | -2.59 | -0.18 | -0.02 | -0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash Flow From Financing Activity ⓘ + | 0.81 | 1.49 | 9.02 | 0.99 | 0 | 4.08 | 1.73 | 0.27 | 0.34 | -0.02 |
| Net Cash Flow ⓘ | 0.08 | -0.96 | -0 | 0.09 | -0.15 | 0.13 | -0.08 | 0.07 | -0.08 | -0.05 |
Financial Ratio
| PARTICULARS | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 0 | 0 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ROCE (%) | -14.94 | -20.55 | -15.82 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Asset Turnover Ratio | 0.58 | 0.08 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PAT to CFO Conversion(x) | N/A | -0.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Days | ||||||||||
| Receivable Days | 21.50 | 92.50 | 315.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 54 | 388.60 | 498.60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable Days | 106.70 | 876.60 | 975.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 62.13 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Unimers India Ltd FAQs
The current trading price of Unimers India on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Unimers India stood at ₹9.02 Cr
The latest P/E ratio of Unimers India as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Unimers India as of 31-Dec-1969 is -0.11.
The 52-week high of Unimers India is ₹5.67 and the 52-week low is ₹5.67.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Unimers India is ₹0.00 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Unimers India Ltd
Unimers India (UIL) was incorporated on November 20, 1987 and received the certificate of Commencement of Business on November 26,1987. The Company has been promoted by Herdillia Chemicals Limited (HCL) in technical collaboration with Uniroyal Chemical Co. Inc. USA belongs to the Duncan Goenka Group.
UIL manufactures Ethylene Propylene (Diene) Rubber (EPM/EPDM) using solution polymerisation process at their state of the art plant situated at Navi Mumbai, India in technical and financial collaboration with the world-renowned Uniroyal Chemical Company Inc. USA, the manufacturer of Royalene EPDM.
Duncan Goenka Group is today highly diversified with 20 operating companies and a workforce of 40,000 employees. Its present turnover of Rs. 20 billion, places it amongst the top ten industrial groups in the country. In its millennium avatar, the Group has identified four thrust areas - power generation and other core sector projects, agro-based ventures, chemicals and petrochemicals and frontier sciences like software and biotechnology. A target of Rs. 100 billion has been set for achievement by 2000 A.D. Unimers India markets their EPM/EPDM under the trade name Herlene®
Product range of the company includes:
- Herlene EPDM- Herlene ® EPDM, a terpolymer of ethylene, propylene and a non conjugated diene is one of the most versatile speciality elastomer in commercial use today. The main attributes of EPDM are its outstanding resistance to Oxidation, Ozone and the effects of weathering. It is also highly extendable, allowing high levels of fillers and plasticizers to be added while still maintaining good physical properties. Herlene’s low specific gravity combined with its high extendability, makes it cost effective for the manufacture of wide range of rubber components.
- Herlene EPDM polymers offer outstanding performance in wire and cable and other electrical applications. Herlene® EPDM compounds can be formulated to provide optimum physical, electrical and ageing properties, combined with excellent wet electrical, flame and treeing resistance.
- Herlene IM
- New Introductions- H-508, H-301T, H-502, H-512, H-511, H-521, H-545 etc.
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
